{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:09:22Z","timestamp":1789646962958,"version":"4.0.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003785","name":"Medical Scientific Research Foundation of Guangdong Province of China","doi-asserted-by":"crossref","award":["B2021265"],"award-info":[{"award-number":["B2021265"]}],"id":[{"id":"10.13039\/501100003785","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515140125"],"award-info":[{"award-number":["2023A1515140125"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Foshan Traditional Chinese Medicine Immune Health Technology Innovation Base"},{"name":"the Science and Technology Innovation Research Program of Jinling Hospital","award":["2023JCYJZD078"],"award-info":[{"award-number":["2023JCYJZD078"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-024-03525-z","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:00:52Z","timestamp":1732780852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Novel non-HDLc\/HDLc ratio for predicting MASLD: a cross-sectional study in a Chinese health screening population"],"prefix":"10.1186","volume":"24","author":[{"given":"Yan","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangtao","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weining","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"issue":"12","key":"3525_CR1","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","volume":"20","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Li X, et al. 2019 global NAFLD prevalence: a systematic review and Meta-analysis[J]. Clin Gastroenterol Hepatol. 2022;20(12):2809\u201317. https:\/\/doi.org\/10.1016\/j.cgh.2021.12.002.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"3525_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1053\/j.gastro.2017.01.003","volume":"152","author":"D Goldberg","year":"2017","unstructured":"Goldberg D, Ditah IC, Saeian K, et al. Changes in the prevalence of Hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the Waitlist for Liver Transplantation[J]. Gastroenterology. 2017;152(5):1090\u20139. https:\/\/doi.org\/10.1053\/j.gastro.2017.01.003.","journal-title":"Gastroenterology"},{"issue":"4","key":"3525_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.14218\/JCTH.2017.00013","volume":"5","author":"JM Pappachan","year":"2017","unstructured":"Pappachan JM, Babu S, Krishnan B, et al. Non-alcoholic fatty liver disease: a clinical Update[J]. J Clin Transl Hepatol. 2017;5(4):384\u201393. https:\/\/doi.org\/10.14218\/JCTH.2017.00013.","journal-title":"J Clin Transl Hepatol"},{"issue":"7","key":"3525_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach[J]. Lancet Gastroenterol Hepatol. 2021;6(7):578\u201388. https:\/\/doi.org\/10.1016\/S2468-1253(21)00020-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"3525_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, et al. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments[J]. Nat Rev Gastroenterol Hepatol. 2021;18(9):599\u2013612. https:\/\/doi.org\/10.1038\/s41575-021-00448-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"3525_CR6","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J]. Gut. 2017;66(6):1138\u201353. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884.","journal-title":"Gut"},{"issue":"6","key":"3525_CR7","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature[J]. J Hepatol. 2023;79(6):1542\u201356. https:\/\/doi.org\/10.1016\/j.jhep.2023.06.003.","journal-title":"J Hepatol"},{"issue":"6","key":"3525_CR8","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, et al. Nonalcoholic fatty liver Disease and Cardiovascular Risk: A Scientific Statement from the American Heart Association[J]. Arterioscler Thromb Vasc Biol. 2022;42(6):e168\u201385. https:\/\/doi.org\/10.1161\/ATV.0000000000000153.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"3525_CR9","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s12072-023-10543-8","volume":"17","author":"XD Zhou","year":"2023","unstructured":"Zhou XD, Targher G, Byrne CD, et al. An international multidisciplinary consensus statement on MAFLD and the risk of CVD[J]. Hepatol Int. 2023;17(4):773\u201391. https:\/\/doi.org\/10.1007\/s12072-023-10543-8.","journal-title":"Hepatol Int"},{"issue":"5","key":"3525_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3904\/kjim.2024.156","volume":"39","author":"H Won","year":"2024","unstructured":"Won H, Bae JH, Lim H, et al. 2024 KSoLA consensus on secondary dyslipidemia[J]. Korean J Intern Med. 2024;39(5):717\u201330. https:\/\/doi.org\/10.3904\/kjim.2024.156.","journal-title":"Korean J Intern Med"},{"issue":"2","key":"3525_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/PAT.0b013e32834f90fe","volume":"44","author":"DA Bell","year":"2012","unstructured":"Bell DA, Hooper AJ, Bender R, et al. Screening for lipid disorders[J]. Pathology. 2012;44(2):115\u201321. https:\/\/doi.org\/10.1097\/PAT.0b013e32834f90fe.","journal-title":"Pathology"},{"key":"3525_CR12","doi-asserted-by":"publisher","first-page":"e67731","DOI":"10.1136\/bmj-2021-067731","volume":"376","author":"A Hodkinson","year":"2022","unstructured":"Hodkinson A, Tsimpida D, Kontopantelis E, et al. Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis[J]. BMJ. 2022;376:e67731. https:\/\/doi.org\/10.1136\/bmj-2021-067731.","journal-title":"BMJ"},{"issue":"4","key":"3525_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jacl.2008.06.013","volume":"2","author":"MJ Blaha","year":"2008","unstructured":"Blaha MJ, Blumenthal RS, Brinton EA, et al. The importance of non-HDL cholesterol reporting in lipid management[J]. J Clin Lipidol. 2008;2(4):267\u201373. https:\/\/doi.org\/10.1016\/j.jacl.2008.06.013.","journal-title":"J Clin Lipidol"},{"issue":"1","key":"3525_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12944-018-0848-8","volume":"17","author":"K Wang","year":"2018","unstructured":"Wang K, Shan S, Zheng H, et al. Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study[J]. Lipids Health Dis. 2018;17(1):196. https:\/\/doi.org\/10.1186\/s12944-018-0848-8.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3525_CR15","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12944-020-01336-1","volume":"19","author":"WS Yang","year":"2020","unstructured":"Yang WS, Li R, Shen YQ, et al. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis[J]. Lipids Health Dis. 2020;19(1):160. https:\/\/doi.org\/10.1186\/s12944-020-01336-1.","journal-title":"Lipids Health Dis"},{"key":"3525_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1476-511X-13-37","volume":"13","author":"W Zhao","year":"2014","unstructured":"Zhao W, Gong W, Wu N, et al. Association of lipid profiles and the ratios with arterial stiffness in middle-aged and elderly Chinese[J]. Lipids Health Dis. 2014;13:37. https:\/\/doi.org\/10.1186\/1476-511X-13-37.","journal-title":"Lipids Health Dis"},{"issue":"19","key":"3525_CR17","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)","year":"2001","unstructured":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)[J]. JAMA. 2001;285(19):2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","journal-title":"JAMA"},{"issue":"1","key":"3525_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12944-020-01421-5","volume":"19","author":"S Yang","year":"2020","unstructured":"Yang S, Zhong J, Ye M, et al. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study[J]. Lipids Health Dis. 2020;19(1):242. https:\/\/doi.org\/10.1186\/s12944-020-01421-5.","journal-title":"Lipids Health Dis"},{"issue":"6","key":"3525_CR19","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell GC, Chitturi S, Lau GK, et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary[J]. J Gastroenterol Hepatol. 2007;22(6):775\u20137. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.05002.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"3525_CR20","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","author":"EASL-EASD-EASO","year":"2016","unstructured":"EASL-EASD-EASO. Clinical practice guidelines for the management of non-alcoholic fatty liver disease[J]. J Hepatol. 2016;64(6):1388\u2013402. https:\/\/doi.org\/10.1016\/j.jhep.2015.11.004.","journal-title":"J Hepatol"},{"issue":"6","key":"3525_CR21","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature[J]. Hepatology. 2023;78(6):1966\u201386. https:\/\/doi.org\/10.1097\/HEP.0000000000000520.","journal-title":"Hepatology"},{"issue":"1","key":"3525_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12944-024-02171-4","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, Wu M, Du R, et al. The relationship between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and hyperuricaemia[J]. Lipids Health Dis. 2024;23(1):187. https:\/\/doi.org\/10.1186\/s12944-024-02171-4.","journal-title":"Lipids Health Dis"},{"issue":"12","key":"3525_CR23","doi-asserted-by":"publisher","first-page":"e34809","DOI":"10.2196\/34809","volume":"8","author":"H Chen","year":"2022","unstructured":"Chen H, Zhan Y, Zhang J, et al. The Global, Regional, and National Burden and trends of NAFLD in 204 countries and territories: an analysis from Global Burden of Disease 2019[J]. JMIR Public Health Surveill. 2022;8(12):e34809. https:\/\/doi.org\/10.2196\/34809.","journal-title":"JMIR Public Health Surveill"},{"issue":"1","key":"3525_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1067\/mva.2000.105949","volume":"32","author":"N Washiyama","year":"2000","unstructured":"Washiyama N, Kazui T, Takinami M, et al. Surgical treatment of recurrent abdominal aortic aneurysm in a patient with systemic lupus erythematosus[J]. J Vasc Surg. 2000;32(1):209\u201312. https:\/\/doi.org\/10.1067\/mva.2000.105949.","journal-title":"J Vasc Surg"},{"issue":"7","key":"3525_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/j.1478-3231.2006.01311.x","volume":"26","author":"S Zelber-Sagi","year":"2006","unstructured":"Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, et al. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures[J]. Liver Int. 2006;26(7):856\u201363. https:\/\/doi.org\/10.1111\/j.1478-3231.2006.01311.x.","journal-title":"Liver Int"},{"issue":"4","key":"3525_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.5604\/01.3001.0012.0922","volume":"17","author":"C Strey","year":"2018","unstructured":"Strey C, de Carli LA, Fantinelli M, et al. Impact of diabetes Mellitus and insulin on nonalcoholic fatty liver disease in the morbidly Obese[J]. Ann Hepatol. 2018;17(4):585\u201391. https:\/\/doi.org\/10.5604\/01.3001.0012.0922.","journal-title":"Ann Hepatol"},{"issue":"5","key":"3525_CR27","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3748\/wjg.v21.i5.1650","volume":"21","author":"Q Pang","year":"2015","unstructured":"Pang Q, Zhang JY, Song SD, et al. Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index[J]. World J Gastroenterol. 2015;21(5):1650\u201362. https:\/\/doi.org\/10.3748\/wjg.v21.i5.1650.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"3525_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3343\/alm.2023.43.1.5","volume":"43","author":"WL Cheng","year":"2023","unstructured":"Cheng WL, Markus C, Lim CY, et al. Calibration practices in Clinical Mass Spectrometry: review and Recommendations[J]. Ann Lab Med. 2023;43(1):5\u201318. https:\/\/doi.org\/10.3343\/alm.2023.43.1.5.","journal-title":"Ann Lab Med"},{"issue":"6","key":"3525_CR29","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1002\/hep.23593","volume":"51","author":"EK Speliotes","year":"2010","unstructured":"Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study[J]. Hepatology. 2010;51(6):1979\u201387. https:\/\/doi.org\/10.1002\/hep.23593.","journal-title":"Hepatology"},{"issue":"4","key":"3525_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1055\/s-0033-1358519","volume":"33","author":"DE Cohen","year":"2013","unstructured":"Cohen DE, Fisher EA. Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease[J]. Semin Liver Dis. 2013;33(4):380\u20138. https:\/\/doi.org\/10.1055\/s-0033-1358519.","journal-title":"Semin Liver Dis"},{"issue":"2","key":"3525_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2013.01.022","volume":"227","author":"AP DeFilippis","year":"2013","unstructured":"DeFilippis AP, Blaha MJ, Martin SS, et al. Nonalcoholic fatty liver disease and serum lipoproteins: the multi-ethnic study of Atherosclerosis[J]. Atherosclerosis. 2013;227(2):429\u201336. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.022.","journal-title":"Atherosclerosis"},{"issue":"5","key":"3525_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","volume":"72","author":"JM Paik","year":"2020","unstructured":"Paik JM, Golabi P, Younossi Y, et al. Changes in the Global Burden of Chronic Liver diseases from 2012 to 2017: the growing impact of NAFLD[J]. Hepatology. 2020;72(5):1605\u201316. https:\/\/doi.org\/10.1002\/hep.31173.","journal-title":"Hepatology"},{"issue":"2","key":"3525_CR33","doi-asserted-by":"publisher","first-page":"e5809","DOI":"10.1097\/MD.0000000000005809","volume":"96","author":"S Pan","year":"2017","unstructured":"Pan S, Hong W, Wu W, et al. The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm[J]. Med (Baltim). 2017;96(2):e5809. https:\/\/doi.org\/10.1097\/MD.0000000000005809.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3525_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12876-017-0696-4","volume":"17","author":"N Wongjarupong","year":"2017","unstructured":"Wongjarupong N, Assavapongpaiboon B, Susantitaphong P, et al. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis[J]. BMC Gastroenterol. 2017;17(1):149. https:\/\/doi.org\/10.1186\/s12876-017-0696-4.","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"3525_CR35","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","volume":"80","author":"H Hagstrom","year":"2024","unstructured":"Hagstrom H, Vessby J, Ekstedt M, et al. 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical[J]. J Hepatol. 2024;80(2):e76\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.026.","journal-title":"J Hepatol"},{"issue":"1","key":"3525_CR36","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"ME Rinella","year":"2024","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature[J]. Ann Hepatol. 2024;29(1):101133. https:\/\/doi.org\/10.1016\/j.aohep.2023.101133.","journal-title":"Ann Hepatol"},{"issue":"5","key":"3525_CR37","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/s0002-9343(99)00271-5","volume":"107","author":"G Marchesini","year":"1999","unstructured":"Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance[J]. Am J Med. 1999;107(5):450\u20135. https:\/\/doi.org\/10.1016\/s0002-9343(99)00271-5.","journal-title":"Am J Med"},{"issue":"5","key":"3525_CR38","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation[J]. Am J Physiol Gastrointest Liver Physiol. 2006;290(5):G852\u20138. https:\/\/doi.org\/10.1152\/ajpgi.00521.2005.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"3525_CR39","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med. 2018;24(7):908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"issue":"3","key":"3525_CR40","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/hep.31250","volume":"72","author":"M Tardelli","year":"2020","unstructured":"Tardelli M, Bruschi FV, Trauner M. The role of metabolic lipases in the Pathogenesis and management of Liver Disease[J]. Hepatology. 2020;72(3):1117\u201326. https:\/\/doi.org\/10.1002\/hep.31250.","journal-title":"Hepatology"},{"key":"3525_CR41","doi-asserted-by":"publisher","first-page":"783976","DOI":"10.1155\/2011\/783976","volume":"2011","author":"TK Fon","year":"2011","unstructured":"Fon TK, Rozman D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation[J]. J Lipids. 2011;2011:783976. https:\/\/doi.org\/10.1155\/2011\/783976.","journal-title":"J Lipids"},{"issue":"2","key":"3525_CR42","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ccr.2006.12.016","volume":"11","author":"T Luedde","year":"2007","unstructured":"Luedde T, Beraza N, Kotsikoris V, et al. Deletion of NEMO\/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma[J]. Cancer Cell. 2007;11(2):119\u201332. https:\/\/doi.org\/10.1016\/j.ccr.2006.12.016.","journal-title":"Cancer Cell"},{"issue":"3","key":"3525_CR43","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease[J]. Gastroenterology. 2002;123(3):745\u201350. https:\/\/doi.org\/10.1053\/gast.2002.35354.","journal-title":"Gastroenterology"},{"issue":"6","key":"3525_CR44","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"S Dasarathy","year":"2009","unstructured":"Dasarathy S, Dasarathy J, Khiyami A, et al. Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study[J]. J Hepatol. 2009;51(6):1061\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2009.09.001.","journal-title":"J Hepatol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-024-03525-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-024-03525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T09:08:50Z","timestamp":1732784930000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-024-03525-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3525"],"URL":"https:\/\/doi.org\/10.1186\/s12876-024-03525-z","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Review Committee of Guangdong Provincial Hospital of Integrative Medicine. Due to the retrospective nature of this study, the Research Ethics Review Committee of Guangdong Provincial Hospital of Integrative Medicine waived the requirement of informed consent. All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}